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Background: The use of cardiac implantable electrical devices continues to increase with the validation of new
beneficial indications. While the risks of device implantation decreased significantly over time, significant risk
remains associated with their extraction when indicated. A high-risk pacemaker lead extraction case is described,
wherein a chronically implanted lead that had perforated the right atrium was successfully removed without the
need for cardiopulmonary bypass. In this report we share our approach to this challenging extraction case and
describe an infrequently utilized off-pump hybrid technique that we term the “lead-inverting stitch”.
Case presentation: A 74 year-old Caucasian woman with complete heart block and remote pacemaker implantation
presents with a swollen and erythematous infected pacemaker pocket necessitating device extraction. Chest
computerized tomographic imaging revealed a chronically perforating right atrial lead tip approximately 2 cm
within the pericardial space. A successful hybrid transvenous and open surgical extraction approach was undertaken
without the need for cardiopulmonary bypass; this was made possible due to a successfully positioned “lead-inverting
stitch”.
Conclusion: Implantable cardiac electrical device infections are amongst the most dreaded post implant complications.
Risks of device extraction are further complicated in cases of chronic lead perforations. Extraction strategies that avoid
cardiopulmonary bypass initiation are preferred.
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The use of cardiac implantable electrical devices (CIEDs)
continues to increase with the validation of new benefi-
cial indications. While the risks of device implantation
decreased significantly over time, significant risk remains
associated with their extraction when indicated. A high-
risk pacemaker lead extraction case is described, wherein
a chronically implanted lead that had perforated the
right atrium was successfully removed without the need
for cardiopulmonary bypass (CPB). In this report we
share our approach to this challenging extraction case
and describe an infrequently utilized off-pump hybrid
technique that we term the “lead-inverting stitch”.* Correspondence: exner@ucalgary.ca
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A 74 year-old Caucasian woman with complete heart
block had dual chamber pacemaker implanted in 1990.
Her initial system included a Medtronic 4504 passive
fixation atrial lead and a Medtronic 4004 passive fixation
ventricular lead. She subsequently underwent replacement
of her pulse generator in 1998 and insertion of a new
Medtronic 5568 active fixation atrial lead and a Medtronic
4068 ventricular leads in August 2003 due to lead failure.
She underwent a subsequent generator change in June
2011. The original atrial and ventricular leads were aban-
doned when the new leads were added in 2003. All proce-
dures had been undertaken at a referring institution and
she had not had any prior open-heart surgical procedures.
The patient presented at her home hospital with a swollen
and erythematous pacemaker pocket in February 2014.
Blood cultures did not grow any bacterial or fungal organ-
isms. A trans-esophageal echocardiogram was performedl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Midline sternotomy depicting the pacemaker lead
perforation through the right atrium (white arrow).
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identified, but there was suspicion that one her atrial lead
was extravascular. She underwent chest computerized
tomographic imaging and this study revealed that one of
her right atrial lead tips was approximately 2 cm within
the pericardial space (Figure 1). The patient was treated
with vancomycin and ceftriaxone based on a diagnosis of
suspected pacemaker pocket infection. She underwent
pacemaker pocket exploration and debridement, but ex-
traction was not undertaken due to the increased risks in-
volved with the lead being extra-vascular. No organism
was identified from samples of fluid cultured during that
initial debridement procedure. Despite that debridement
procedure and prolonged antibiotics there was clinical re-
currence of the infection and the patient was subsequently
transferred to our center for complex lead extraction.
To minimize the risk of vascular disruption and tam-
ponade given the chronic right atrial lead perforation, a
combined transvenous and open surgical extraction ap-
proach was undertaken. Using a dedicated hybrid oper-
ating theatre with cardiopulmonary bypass support if
necessary, midline sternotomy was performed. Dense ad-
hesions were found within the pericardial space consist-
ent with likely prior pericarditis. Given the location of
the RA lead, care was taken to leave the right atrial dis-
section until all other vascular structures were exposed.
With uneventful dissection of the right atrium, direct
visualization of the protruding passive fixation lead was
obtained (Figure 2). To avoid the risks associated with
cardiopulmonary bypass and given the good visualization
of the perforating atria lead, an off-pump technique was
considered using a “lead-inverting stitch”. To achieve
hemostatic control over the region of the atrial wallFigure 1 Non-contrast computerized tomography image
depicting the extravascular portion of the right atrial
pacemaker lead (arrow).where the lead exited, a purse-string stitch was placed
circumferentially around the lead tip using 3–0 prolene
with multiple pledgets (Figure 3A). The externalized tip
of the perforating atrial lead was then mobilized by cut-
ting a rim of surrounding atrial tissue. This allowed the
end of the lead to be dunked within the right atrial
chamber while the purse-string suture was tightened for
hemostasis (Figure 3B and C). With this “lead inverting
stitch”, the lead was free within the right atrium and
could now be safely extracted using transvenous laser
extraction techniques.
With the heart partially verticalized, the lateral wall of
the left ventricle was exposed and an epicardial lead
(Medtronic 4968) was placed. It was then tunnelled
through the subcutaneous tissue above the rectus sheath,
secured and connected to the new pacemaker. The new
pacemaker was then placed in a newly created pocket,
below the left costal margin. The sternotomy wound was
covered with sterile surgical towels.
The infected pacemaker pocket was then opened and
direct visualization confirmed the presence of a small
amount of murky fluid. This fluid was sent for culture.
The pocket was then extensively debrided and the four
transvenous pacemaker leads were prepared for complex
extraction in a standard manner beginning with retrac-
tion of the distal screw to facilitate separation of the ac-
tive fixation lead tip from the myocardium interface
during laser extraction. A purse string suture was subse-
quently positioned along the pectoral muscle around
each lead at its insertion site to avoid any significant
bleeding when the leads are completely removed. The
lumen of each lead was then probed for patency with a
standard stylet to ensure that a lead-locking-stylet can
be utilized and advanced deep into the lead lumen for
Figure 3 Illustration of the “lead inverting stitch”. A. Purse-string suture applied around the perforating lead. B. Atrial lead-tip severed with heavy
scissors followed by inversion of the remnant atrial lead fragment and surrounding scar beneath the tightened purse-string. Note: the epicardial pacing
lead is already in place. C. Cross-section illustration of the severed and inverted atrial lead following tightening of the purse string around the
lead (i.e., “lead inverting stitch”).
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priate sizing of each lumen and distal delivery of the
locking stylets was subsequently performed. A long silk
suture thread was then tied to the outside of the lead
near its insertion site, extended along the length of the
lead, and tied to its end to provide further support along
with the lead-locking-stylet when applying traction on
the lead during laser extraction. Now that the leads have
been prepared, transvenous lead extraction with a #14
French laser sheath was attempted. Due to the presence
of multiple biding sites, up-sizing to a #16 laser sheath
was required along with the use of a less compliant
outer sheath (Visi-sheath). All the leads were removed
entirely, with the perforating atrial lead removed last.
There was no hemodynamic compromise throughout
the procedure and no mechanical complications related
to the procedure. The “lead inverting stitch” retained its
integrity and hemostasis was preserved throughout the
transvenous lead extraction.
Following successful lead extraction, the median ster-
notomy and old pacemaker pocket incisions were closed
in a standard fashion and the patient was transferred to
the intensive care unit for post-operative monitoring.
The total procedure time from incision to woundclosure was 5 hours and 24 minutes. Post-operative
course was complicated with hypoxia secondary to atel-
ectasis and aspiration pneumonia that resolved after 5
days. The patient was discharged back to her home hos-
pital for ongoing rehabilitation.
Discussion
A high-risk pacemaker lead extraction case is described,
wherein a chronically implanted (>20 years) passive fix-
ation lead that had perforated the right atrium was suc-
cessfully removed without the need for CPB. To our
knowledge such combined surgical and transvenous (hy-
brid) lead extraction procedures are typically completed
with the patient on cardiopulmonary bypass. Our case
presentation highlights how an off-pump hybrid ap-
proach utilizing a “lead-inverting stitch” can be consid-
ered and is likely preferred since it allows for an
extravascular lead to be safely removed while avoiding
the risks associated with cardiopulmonary bypass. This
less invasive approach should be considered if adequate
visualization of the perforating lead can be achieved.
The use of CIEDs continues to increase yearly with
the validation of new beneficial and life saving clinical
indications. In 2009 alone over 1.3 million CIEDs were
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plantation have decreased significantly over time, there
are significant risks associated with the removal of im-
planted devices as illustrated in the described case.
Based on a recent Danish nationwide cohort of over
5,000 consecutive patients undergoing CIED placement
nearly 10% of recipients experienced at least one compli-
cation. Risk factors for complications included patient
factors, an implant centre annual volume of < 750 CIED
procedures, an annual operator volume <50 CIED pro-
cedures, system upgrade or lead revision and emergency
or out-of-hours procedures. The most common major
complication was lead related re-intervention, followed
by infection. Cardiac perforation was identified in 0.6%
of cases [2].
Complete CIED system removal, typically related to
infection, is problematic. In high-volume centers, the
risk of lead extraction still exceeds 5% and includes both
major (1.8%) and minor (3.6%) complications [3]. In
more typical centers the risk are likely much higher. For
example, the risk of complications with lead revisions
has been shown to be as high as 14.5%, with 7.25% of
these being categorized as major complications [4].
Predictors of major complications with transvenous
lead extraction include a history of cerebrovascular dis-
ease, an ejection fraction <15%, a reduced platelet count,
an international normalized ratio >1.2, the need for
mechanical sheaths or powered sheaths for lead removal
[3,4]. Predictors of all-cause mortality within 30 days of
extraction include a low weight, end-stage renal disease,
higher New York Heart Association function class, lower
haemoglobin, lead extraction for infection and extraction
of a dual-coil implantable cardioverter defibrillator leads
[3]. Thus, it is essential to carefully weigh the benefit
and risk ratio when considering a patient for extraction.
Most leads are presently removed via transvenous ex-
traction. In experienced centers procedural success ex-
ceeds 95.1% [3]. The presence of a lead or portion of it
outside of the normal vascular space is an absolute
contra-indication to transvenous lead extraction [5]. The
case described is an example of such a patient. These pa-
tients are at much higher risk due to the potential for
rapid exsanguination. A hybrid lead extraction approach
involving midline or minimally invasive right thoracot-
omy in addition to transvenous extraction has been de-
scribed and is reserved for high-risk cases where surgical
intervention is deemed necessary for patient safety and
to achieve clinical success [6,7].
Hybrid lead extraction procedures are not devoid of add-
itional risks compared to isolated transvenous lead removal,
particularly when cardiopulmonary bypass (CPB) is re-
quired. The incidence of intra- and post-operative compli-
cations associated with CPB, including mortality, increase
exponentially with age [8]. The adage of “less is better”applies to every step of a hybrid lead extraction procedure.
The described surgical technique of a “lead inverting stitch”
allows the safe removal of an extravascular lead without the
need for CPB; initiating patients on CPB is commonly done
nowadays during hybrid extraction procedures where an
atriotomy is necessary to surgically removal a perforating
lead. This “lead inverting stitch” offers an alternative surgi-
cal approach in cases where avoidance of CPB is desirable.
While the described technique is by no means infallible,
this case illustrates that with adequate direct visualization,
careful monitoring and direct surgical standby an extravas-
cular lead can be removed without the initiation of CPB.
Further, the described hybrid procedure was reasonably
time efficient, with a procedural time of 5 hours and 24 mi-
nutes versus mean operative times of 13 hours when CPB
is used as part of hybrid extraction procedures [6].Conclusion
Cardiac device infections represent serious complications,
since complete system removal is typically necessary.
Complex lead extraction is further complicated in cases,
like that presented, where the lead or part of the lead is
extra-cardiac. Recognition of this situation pre-operatively
is essential to appropriate operative planning. A hybrid
approach that avoids the need for cardiopulmonary bypass,
like that described in this case, is preferred in order to
minimize risk.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
CIEDs: Cardiac implantable electrical devices; CPB: Cardiopulmonary bypass.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JR, WK, VK, JB, DE were equally involved in the care of the patient and case
report composition. JR was the artist and creator of Figure 3. All authors read
and approved the final manuscript.
Received: 4 August 2014 Accepted: 24 February 2015
References
1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and
implantable cardioverter-defibrillators: calendar year 2009; a World Society
of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–27.
2. Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications
after cardiac implantable electronic device implantations: an analysis of a
complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.
3. Brunner MP, Cronin EM, Duarte VE, Tarakji KG, Martin DO, Callahan T, et al.
Clinical predictors of adverse patient outcomes in an experience of more
than 5000 chronic endovascular pacemaker and defibrillator lead
extractions. Heart Rhythm. 2014;11(5):799–805.
Rizkallah et al. BMC Research Notes  (2015) 8:94 Page 5 of 54. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, et al.
Complications associated with revision of Sprint Fidelis leads: Report from
the Canadian Heart Rhythm Society Device Advisory Committee. Circ.
2010;121:2384–7.
5. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd,
et al. Transvenous lead extraction: Heart Rhythm Society expert consensus
on facilities, training, indications and patient management. Heart Rhyhtm.
2009;6(7):1085–104.
6. Koneru J, Ellenbogen K. High-risk lead extraction using a hybrid approach:
the blade and the lightsaber. J Cardiovasc Electrophysiol. 2014;25(6):622–3.
7. Goyal SK, Ellis CR, Ball SK, Ahmad R, Hoff SJ, Whalen SP, et al. High-risk lead
removal by planned sequential transvenous laser extraction and minimally
invasive right thoracotomy. J Cardiovasc Electrophysiol. 2014;25(6):617–21.
8. Tuman KJ, MacCarthy RJ, Najafi H, Ivankovich AD. Differential effects of
advanced age on neurologic and cardiac risks of coronary artery operations.
J Thorac Cardiovasc Surg. 1992;104(6):1510.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
